Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS celebrates research excellence
2016-02-25

Description: UFS celebrates research excellence Tags: UFS celebrates research excellence

Researchers at the university were acknowledged for their new research ratings. From the left are: Prof Johann de Wet, Department of Communication Sciences; Prof Naomi Morgan, Department of Afrikaans and Dutch, German and French; Prof Corli Witthuhn, Vice-Rector: Research; Prof André Pelser, Department of Sociology; Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology; and Prof Riaz Seedat, Department Otorhinolaryngology.

During a recent gala occasion, the University of the Free State (UFS) acknowledged 15 of its researchers who received new ratings from the National Research Foundation (NRF).

According to Prof Corli Witthuhn, Vice-Rector: Research at the UFS, 37 applications have already been received for the next round of ratings by the NRF. In recent years, the university has experienced an increase in the rating of its researchers as the result of raised academic standards. These are in line with the Academic Project of the UFS. The UFS has 125 rated researchers in total.

The 15 recipients of new ratings from the NRF in 2015,are:

- Dr Tanya Beelders, Computer Science: Y2
- Dr Andrew Cohen, History: Y1
- Prof Pieter de Villiers, Theology: C2
- Prof Johann de Wet, Communication: C3
- Dr Angelinus Franke, Agriculture: C2
- Prof Jonathan Jansen, Education: B1
- Prof Riaan Luyt, Chemistry: B3
- Prof Naomi Morgan, Linguistics: C2
- Dr Trudi O’Neill, Microbiology: C1
- Prof André Pelser, Sociology: C3
- Dr Johann Rossouw, Philosophy: C2
- Prof Riaz Seedat, Health: C3
- Dr Jakub Urbaniak, Theology: Y2
- Dr Martin van Zyl, Mathematics: C3
- Prof Sue Walker, Soil, Crop and Climate Sciences: C1

The UFS also celebrated its five SARChI research chairs during this event. The main goal of the research chairs is to promote research excellence.

The five research chairs at the UFS are all established at Tier 1. Research chairs in the Tier 1 category are based on the researcher's research track record, as well as on the training record of his/her postgraduate and postdoctoral students.  Tier 1 research chairs are awarded to established researchers who are leaders in their field, and whose work is recognised internationally.

The following research chairs have been awarded to the UFS since 2013:

- Solid State Luminescent and Advanced Materials, Prof Hendrik Swart in the Department of Physics (2013-2017)
- Disease Resistance and Quality in Field Crops, Prof Maryke Labuschagne (2016-2020)
- Higher Education and Human Development, Prof Melanie Walker (2013-2017)
- Vector-Borne and Zoonotic Pathogens, Prof Felicity Burt (2016-2020)
- Humanities without Borders: Trauma, History and Memory (2016-2020) 

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept